APA (7th ed.) Citation

Prins, H., Zino, L., Svensson, E., Verbon, A., de Bree, G., Prins, J., . . . Colbers, A. (2023). Exposure and virologic outcomes of dolutegravir combined with ritonavir boosted darunavir in treatment-naïve individuals enrolled in the Netherlands Cohort Study on Acute HIV infection (NOVA). International Journal of Antimicrobial Agents, 61(1), N.PAG. https://doi.org/10.1016/j.ijantimicag.2022.106697

Chicago Style (17th ed.) Citation

Prins, H.A.B, et al. "Exposure and Virologic Outcomes of Dolutegravir Combined with Ritonavir Boosted Darunavir in Treatment-naïve Individuals Enrolled in the Netherlands Cohort Study on Acute HIV Infection (NOVA)." International Journal of Antimicrobial Agents 61, no. 1 (2023): N.PAG. https://doi.org/10.1016/j.ijantimicag.2022.106697.

MLA (9th ed.) Citation

Prins, H.A.B, et al. "Exposure and Virologic Outcomes of Dolutegravir Combined with Ritonavir Boosted Darunavir in Treatment-naïve Individuals Enrolled in the Netherlands Cohort Study on Acute HIV Infection (NOVA)." International Journal of Antimicrobial Agents, vol. 61, no. 1, 2023, p. N.PAG, https://doi.org/10.1016/j.ijantimicag.2022.106697.